2024-04-19  5:30:11 PM Chg. +0.40 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
81.40CHF +0.49% 2,974
Turnover: 241,270.85
81.00Bid Size: 245 82.10Ask Size: 97 1.01 bill.CHF - 1,628.00

Business description

As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland.
 

Management board & Supervisory board

CEO
Christoph Brönnimann
Management board
Dirk Kirsten, Manuel Schaer, Anthony Durieux-Menage, Mareike Loch, Mario Della Casa
Supervisory board
Marco Gadola, Dr h.c. Thomas Straumann, Damien Tappy, Willi Miesch, Nadia Tarolli Schmidt, Ciro Roemer, Martha Shadan, Jennifer Dean
 

Company data

Name: Medartis Holding AG
Address: Hochbergstraße 60E,CH-4057 Basel
Phone: +41-61-633-34-34
Fax: +41-61-633-34-00
E-mail: info@medartis.com
Internet: www.medartis.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: -
IPO date: 2018-03-23

Investor relations

Name: -
IR phone: -
IR Fax: -
IR e-mail: investor.relations@m...tis.com investor.relations@medartis.com

Company calendar

CW 34 | 2024-08-20 Interim Report 2nd Quarter/6 Months
CW 17 | 2025-04-25 General Shareholder Meeting
 

Main Shareholders

Dr. h.c. Thomas Straumann
 
45.50%
Others
 
22.90%
Nordflint Capital Partners Fondsmaeglerselskab A/S
 
12.80%
NexMed Holding AG
 
7.50%
Endeavour Medtech Growth LP
 
6.30%
Willi Miesch
 
5.00%